Articles and Insights About Wearables for Clinical Trials

Articles by Ieuan Clay, PhD

Ieuan Clay, PhD

Ieuan Clay, PhD, VivoSense Director of Science focuses on translating innovations in the ability to collect data into insights which improve decision making. Combining strategy and science, Ieuan leads research which develops capabilities or products. His current focus is on how initial progress in digital health can be built upon to create a more engaging, holistic and valuable experience for patients, delivering validated, qualified outcomes that help individuals manage and navigate their own health journey.

Find me on:

Recent Articles


Changing Perspectives in Digital Measure Development

 Ieuan Clay, PhD

Ieuan Clay, VivoSense Director of Science, presented at the Mobilise-D Conference to discuss what can be measured, what should be measured, and what must be measured, along with some examples of putting it into practice. Watch the video or check out his slides for a quick snapshot of his presentation!

Read More

Implementing Patient-Centric Solutions in Digital Evidence Generation

 Ieuan Clay, PhD

We all know it's important to choose “measures that matter” when selecting and developing digital measures for evidence generation in clinical trials, but how do we put these good intentions into action? How do we lay solid, patient-centric foundations, whether that means designing a protocol, building an integrated evidence plan, or qualifying a novel evidence tool?

Read More

Reverse Engineering Digital Measures: A Patient-Centric Approach

 Ieuan Clay, PhD

In September 2022, a broad range of stakeholders representing regulators, Pharma and Biotech firms, technology service providers, innovators, and patients gathered in Zürich. This meeting, the second in a series hosted by the Swiss Federal Institute of Technology and the Foundation for the National Institutes of Health Biomarkers Consortium, sought to explore the role patient centricity must play in the development and validation of digital tools for gathering evidence. Director of Science Ieuan Clay, a member of the Biomarkers Consortium, represented VivoSense in the discussion examining four case studies of interest:

Read More

VivoSense Joins CancerX to Advance Digital Innovation in Research

 Ieuan Clay, PhD

On June 2, 2023, at ASCO, CancerX, a public-private partnership co-hosted by Moffitt Cancer Center and the Digital Medicine Society (DiMe), along with the Office for the National Coordinator for Health Information Technology (ONC) and the Office of the Assistant Secretary for Health (OASH), announced its founding members. VivoSense is proud to be among other organizations striving to eradicate cancer!

Read More
 Newer All Articles Older 

Stay Connected

Popular